See also this year's filing and all EDGAR filings for this company.
PDF Report 0001321834_2022_MyMD_Pharmaceuticals_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.3286631469974647, 'aggregate_val': 24812933, 'exp_sum': 36960481, 'exp_to_value': {'AssetsCurrent': 12665385, 'AssetsNoncurrent': 12147548, 'PropertyPlantAndEquipmentNet': 0, 'Goodwill': 10498539, 'remainder_Assets': 1649009}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001321834')"} |
Graph
Absolute values for 0001321834, MyMD Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 125,893 |
| 1 | LiabilitiesCurrent | 1,039,866 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 12,665,385 |
| 4 | AssetsNoncurrent | 12,147,548 |
| 5 | PropertyPlantAndEquipmentNet | 0 |
| 6 | Goodwill | 10,498,539 |
| 7 | remainder_Assets | -10,498,539 |
| 8 | GeneralAndAdministrativeExpense | 6,420,092 |
| 9 | ResearchAndDevelopmentExpense | 6,745,104 |
| 10 | remainder_Expenses | 15,644,511 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,079,338 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 1,165,759 |
| 1 | Assets | 24,812,933 |
| 2 | Expenses | 28,809,707 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 23,647,174 |
| 5 | NetIncome | -29,889,045 |
| 6 | ComprehensiveNetIncome | -29,889,045 |
| 7 | BaseVar | 27,933,868 |
| 8 | EconomicCapitalRatio | -0.754 |
Edgar->Model Mapping
Feature Distribution
Change over Time
